Clostridium difficile is the main cause of community and nosocomial diarrhea associated with antibiotic treatment and has major health care and economic impacts (1-3).Three toxins, toxin A (TcdA, enterotoxin), toxin B (TcdB, cytotoxin), and binary toxin CDT (Clostridium difficile transferase), are produced by C. difficile. CDT is present in only a subset of strains, and its role in pathogenesis is increasingly recognized but still unclear (4). Toxins A and B are the main virulence factors causing damage to the intestinal epithelium and producing diarrhea and inflammation. They are also a main target for enzymebased or molecular diagnostic tests (5, 6). Genes encoding TcdA and TcdB are located on the chromosome and together with three additional genes (tcdR, tcdE, and tcdC) form a 19.6-kb pathogenicity locus (PaLoc). The genes for CDT toxin are located elsewhere on the chromosome (CdtLoc).C. difficile strains can be differentiated based on different patterns of toxin production. Strains which do not produce any of the toxins are nontoxinogenic and do not cause disease. The majority of toxigenic strains are TcdA and TcdB positive (A ϩ B ϩ ), but some strains produce only TcdB (A Ϫ B ϩ ). Toxigenic strains can be further differentiated into toxinotypes based on changes (deletions, insertions, single nucleotide polymorphisms [SNPs]) in the PaLoc. By 2008, 24 different toxinotypes had been published (7), and currently, 31 toxinotypes, designated by roman numbers from I to XXXI, are differentiated (see http://www.mf.uni-mb.si /tox/). Here, we describe a case history and the isolation and characterization of a new A Ϫ B ϩ variant of C. difficile. Case Report. A 68-year-old Spanish male followed as an outpatient at the Gregorio Marań on University Hospital of Madrid because of ischemic cardiomyopathy, angina, and chronic pancreatitis was admitted to the emergency department in October 2011 with a 21-day history of diarrhea. The patient did not have fever, and his general condition was good, but he reported a recent weight loss of 5 kg. Stool microbiological studies were requested at the emergency department for enteropathogens, antigens of rotavirus and adenovirus, intestinal parasites, and C. difficile culture and toxin detection. A direct cytotoxicity assay was performed by centrifuging stool specimen dilutions (1/40) made with phosphate-buffered saline and filtering 500 l of supernatant onto monolayers of human MRC-5 fibroblasts. A test result was considered negative only after 48 h of incubation at 37°C. The specificity of the cytopathic effect was confirmed using a neutralizing high-titer C. difficile antitoxin (TechLab) following the manufacturer's instructions.The rapid detection of glutamate dehydrogenase (GDH) and toxins A and B (C. diff Quik Chek Complete; Techlab, Blacksburg, VA) was also performed on stool specimens showing positive results for GDH but negative results for toxins A and B. Following international recommendations (5, 6), the GeneXpert C. difficile assay (Cepheid, Sunnyvale, CA, USA) was then p...